This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

16 Small-Cap Stocks in Danger of Delisting

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Bionovo (BNVI)

Company Profile: Bionovo is a clinical-stage drug discovery and development company focusing on women's health and cancer.

Current Share Price: 64 cents (March 29)

Listing Violation: Bid price. The listing rule requires that a company maintains a minimum closing bid price of $1 per share for its common stock. Bionovo shares last closed above $1 on Jan. 27.

Received Nasdaq Notice: March 14

Management's Expected Action: Bionovo has until Sept. 12 to regain compliance with the minimum bid price rule. The company said it intends to use its best efforts to regain compliance with Nasdaq's minimum bid requirement.

Parametric Technology (PMTC)

Company Profile: Parametric Technology develops, markets and supports product-development software solutions and related services that help companies design products, manage product information and improve their product development processes.

Current Share Price: $21.90 (March 29)

Listing Violation: Board independence. The listing rule requires the board of directors to have a majority of members who are independent.

Received Nasdaq Notice: March 15

Management's Expected Action: Parametric said the company is conducting a search for an additional member of its board of directors with the intention of appointing the new director "as soon as practicable." After Parametric had an annual meeting of shareholders March 9, the company had an equal number of independent and non-independent directors. The company said it has until Sept. 6 to regain compliance.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

3 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
CLWR $0.00 0.00%
CAAS $7.16 0.00%
RPRX $8.43 0.00%
AAPL $130.28 0.00%
FB $81.53 0.00%


DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs